Overall, the data obtained indicate that high expression of TSN contributes to NSCLC chemoresistance and knockdown of TSN expression promotes a sustained sensitizing effect upon cisplatin treatment. The gene discussed is TSN; the disease is non-small cell lung carcinoma.